8-K
filed February 28, 2025, 6:59 PM ET
ticker SHPH
CIK 0001757499
debt
confidence high
sentiment negative
materiality 0.70
Shuttle Pharmaceuticals enters $2M revolving loan at 18%, replaces four directors with lender nominees
Shuttle Pharmaceuticals Holdings, Inc.
- Revolving loan up to $2M from Bowery Consulting Group; 18% annual interest, 1-year maturity.
- Proceeds for general corporate purposes, including financing a potential $6M public offering.
- Four directors (Milton Brown, Bette Jacobs, Chris Senanayake, Joshua Schafer) resigned; three lender nominees appointed.
- Events of default allow acceleration at 120% of outstanding principal plus interest and costs.
- Financial advisor WestPark Capital received $20K fee and 4% fee on each draw.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001493152-25-008742
- form_type
- 8-K
- ticker
- SHPH
- cik
- 0001757499
- company_name
- Shuttle Pharmaceuticals Holdings, Inc.
- filed_at
- 2025-02-28T23:59:59+00:00
- discovered_at
- 2026-05-14T18:03:04.742265+00:00
- generated_at
- 2026-05-25T23:46:00.666157+00:00
- sec_items
- ["1.01", "2.03", "5.02", "9.01"]
- event_type
- debt
- sentiment
- negative
- materiality_score
- 0.7
- calibrated_materiality_score
- 0.7
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001493152-25-008742
- json_url
- https://secwatch.observer/filing/0001493152-25-008742.json
- markdown_url
- https://secwatch.observer/filing/0001493152-25-008742.md
- text_url
- https://secwatch.observer/filing/0001493152-25-008742.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1757499/000149315225008742/0001493152-25-008742-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1757499/000149315225008742/form8-k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Source-grounded claims
5bbf98153f
Joseph Tung was appointed as Director at Shuttle Pharmaceuticals Holdings, Inc..
the Company’s Board of Directors appointed George Scorsis, Joseph Tung, and Oleh Nabyt as directors of the Company
SEC 8-K Item 5.02
confidence 0.95
SEC evidence
62c756643e
Oleh Nabyt was appointed as Director at Shuttle Pharmaceuticals Holdings, Inc..
the Company’s Board of Directors appointed George Scorsis, Joseph Tung, and Oleh Nabyt as directors of the Company
SEC 8-K Item 5.02
confidence 0.95
SEC evidence
6c407816d7
Chris Senanayake resigned as Director at Shuttle Pharmaceuticals Holdings, Inc..
each of Milton Brown, Bette Jacobs, Chris Senanayake and Joshua Shafer resigned as directors of the Company
SEC 8-K Item 5.02
confidence 0.95
SEC evidence
86e16ed25a
George Scorsis was appointed as Director at Shuttle Pharmaceuticals Holdings, Inc..
the Company’s Board of Directors appointed George Scorsis, Joseph Tung, and Oleh Nabyt as directors of the Company
SEC 8-K Item 5.02
confidence 0.95
SEC evidence
b3ea0fd24f
Milton Brown resigned as Director at Shuttle Pharmaceuticals Holdings, Inc..
each of Milton Brown, Bette Jacobs, Chris Senanayake and Joshua Shafer resigned as directors of the Company
SEC 8-K Item 5.02
confidence 0.95
SEC evidence
c9ccd02486
Joshua Shafer resigned as Director at Shuttle Pharmaceuticals Holdings, Inc..
each of Milton Brown, Bette Jacobs, Chris Senanayake and Joshua Shafer resigned as directors of the Company
SEC 8-K Item 5.02
confidence 0.95
SEC evidence
cdcd0097f6
Bette Jacobs resigned as Director at Shuttle Pharmaceuticals Holdings, Inc..
each of Milton Brown, Bette Jacobs, Chris Senanayake and Joshua Shafer resigned as directors of the Company
SEC 8-K Item 5.02
confidence 0.95
SEC evidence
Comparable filings
FDXF
FedEx Freight completes spin-off from FedEx; $600M drawn, new board and executives appointed
FedEx Freight Holding Company, Inc.
June 1, 2026, 6:46 AM ET
other_material
Items 1.01, 2.03, 3.03, 5.03, 5.01, 5.02, 5.05, 8.01, 9.01
same fact type: executive_change
same SEC item: 1.01, 2.03, 5.02, 9.01
similar materiality
This filing
the Company’s Board of Directors appointed George Scorsis, Joseph Tung, and Oleh Nabyt as directors of the Company
Comparable filing
each of John A. Smith, R. Brad Martin, Jeffrey A. Davis, Donald E. Frieson, Stephen E. Gorman, Robert A. King, Cindy J. Miller, Amy J. Salcido, and Samantha M. Smith was appointed to the Board
Filing page
SEC filing
DGAC
Disciplined Growth Acquisition Corp. closes $150M IPO on NYSE
DISCIPLINED GROWTH ACQUISITION Corp
June 1, 2026, 4:15 PM ET
other_material
Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01
same fact type: executive_change
same SEC item: 1.01, 5.02, 9.01
similar materiality
This filing
the Company’s Board of Directors appointed George Scorsis, Joseph Tung, and Oleh Nabyt as directors of the Company
Comparable filing
John W. Heilshorn, Aaron Spool, Michael Faber, John Ziegelman and Jay Gettenberg (collectively, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
Filing page
SEC filing
BSBK
Bogota Financial Corp. to merge with GSL Savings Bank; assets expected to exceed $1B
Bogota Financial Corp.
June 1, 2026, 9:12 AM ET
m_and_a
Items 1.01, 5.02, 8.01, 9.01
same fact type: executive_change
same SEC item: 1.01, 5.02, 9.01
similar materiality
This filing
the Company’s Board of Directors appointed George Scorsis, Joseph Tung, and Oleh Nabyt as directors of the Company
Comparable filing
Mr. Giancola will become Executive Vice President and Chief Operating Officer of the Bank.
Filing page
SEC filing
FXAC
FortuneX Acquisition closes IPO of 8.625M units at $10/unit, raising $86.25M gross
FortuneX Acquisition Corp
May 29, 2026, 5:32 PM ET
other_material
Items 1.01, 3.02, 5.02, 5.03, 9.01
same fact type: executive_change
same SEC item: 1.01, 5.02, 9.01
similar materiality
This filing
the Company’s Board of Directors appointed George Scorsis, Joseph Tung, and Oleh Nabyt as directors of the Company
Comparable filing
Effective May 19, 2026, in connection with the effectiveness of the Company’s Registration Statement, Becky Fallon, Sean Michael Deegan, and Robert Labbe became members of the board of directors (the “Board”) of the Company.
Filing page
SEC filing
CRMT
America's Car-Mart forms special committee for strategic alternatives; appoints new independent director
AMERICAS CARMART INC
May 29, 2026, 5:30 PM ET
other_material
Items 1.01, 5.02, 8.01, 9.01
same fact type: executive_change
same SEC item: 1.01, 5.02, 9.01
similar materiality
This filing
the Company’s Board of Directors appointed George Scorsis, Joseph Tung, and Oleh Nabyt as directors of the Company
Comparable filing
On May 22, 2026, the Board increased the size of the Board from nine members to ten members and appointed Adam Paul as an independent director, effective immediately.
Filing page
SEC filing
COR
Cencora appoints Eva Boratto as EVP and CFO, effective June 29, 2026; reaffirms FY2026 EPS guidance $17.70-$17.90
Cencora, Inc.
May 29, 2026, 5:10 PM ET
leadership
Items 5.02, 1.01, 7.01, 9.01
same fact type: executive_change
same SEC item: 1.01, 5.02, 9.01
similar materiality
This filing
the Company’s Board of Directors appointed George Scorsis, Joseph Tung, and Oleh Nabyt as directors of the Company
Comparable filing
On May 27, 2026, Cencora, Inc. (the “Company”) announced that Eva C. Boratto has been appointed Executive Vice President and Chief Financial Officer of the Company (the “Appointment”), effective June 29, 2026 (the “Effective Date”).
Filing page
SEC filing
NNE
Nano Nuclear acquires STS for up to $13M, adds nuclear logistics and $7.1M revenue
Nano Nuclear Energy Inc.
May 29, 2026, 6:30 AM ET
m_and_a
Items 1.01, 2.01, 3.02, 5.02, 7.01, 9.01
same fact type: executive_change
same SEC item: 1.01, 5.02, 9.01
similar materiality
This filing
the Company’s Board of Directors appointed George Scorsis, Joseph Tung, and Oleh Nabyt as directors of the Company
Comparable filing
Roy A. Boyd, II , 59, joined the Company as President of STS on May 22, 2026.
Filing page
SEC filing
CRVL
CorVel CEO Michael Combs to become Executive Chair; Sarah Scott appointed CEO and President effective July 1, 2026
CORVEL CORP
June 1, 2026, 5:05 PM ET
leadership
Items 5.02, 7.01, 9.01
same fact type: executive_change
same SEC item: 5.02, 9.01
similar materiality
This filing
the Company’s Board of Directors appointed George Scorsis, Joseph Tung, and Oleh Nabyt as directors of the Company
Comparable filing
In connection with the leadership transition, the Board appointed Sarah Scott to serve as Chief Executive Officer and President of the Company, effective July 1, 2026.
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.